American College of Cardiology

MARCH 4, 2024

The goal of the TALOS-AMI trial was to assess whether de-escalating dual antiplatelet therapy (DAPT) with clopidogrel rather than ticagrelor 1 month after percutaneous coronary intervention (PCI) for an acute myocardial infarction (AMI) would be a noninferior strategy.

Myocardial Infarction 57

Myocardial Infarction Article 57

Open Heart

JANUARY 17, 2024

Objective In the COVERT-MI randomised placebo-controlled trial, oral administration of high-dose colchicine at the time of reperfusion and for 5 days in acute ST-elevated myocardial infarction did not reduce infarct size but was associated with a significant increase in left ventricular thrombus (LVT) in comparison to placebo.

Myocardial Infarction 96

Myocardial Infarction Quality of Life Heart Failure Arrhythmia 96

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

Background The diagnosis of a left ventricular (LV) thrombus in patients with ST-segment elevation myocardial infarction (STEMI) remains challenging. The aim of the current study is to characterize clinical predictors for LV thrombus formation, as detected by cardiac magnetic resonance imaging (CMRI). and 59%, respectively.

Myocardial Infarction 80

Myocardial Infarction STEMI Hospital 80

American College of Cardiology

APRIL 6, 2024

The goal of the EMPACT-MI trial was to determine whether adding the sodium-glucose cotransporter-2 (SGLT2) inhibitor empagliflozin to the treatment of acute myocardial infarction (AMI) affects future mortality or heart failure (HF) in at-risk patients.

Myocardial Infarction 64

Myocardial Infarction Heart Failure Hospital Article 64

Heart BMJ

FEBRUARY 23, 2024

For life-threatening events involving complete occlusion of a coronary artery, the activation of ST-elevation myocardial infarction protocols instructs the emergency services to provide immediate treatment and liaise directly with cardiac centres regarding invasive management, in turn, reducing morbidity and saving lives.

Myocardial Infarction 52

Myocardial Infarction Chest Pain Plaque 52

The American Journal of Cardiology

FEBRUARY 23, 2024

Publication date: Available online 23 February 2024 Source: The American Journal of Cardiology Author(s): Cunrong Huang, Jingang Yang, Ling Li, Shenghu He, Xuxia Zhang, Haiyan Xu, Yuan Wu, Jun Zhang, Shubin Qiao, Yongjian Wu, Yanyan Zhao, Yang Wang, Wei Li, Chen Jin, Xiaojin Gao, Yuejin Yang, CAMI (China Acute Myocardial Infarction) Registry Study (..)

Myocardial Infarction 40

Myocardial Infarction 40

ECG Guru

JULY 26, 2023

76-year-old man, with a history of inferior wall myocardial infarction. He experiences recurrent episodes of brief palpitations, often lasting only 5-15 seconds. In this ECG, at the beginning, the last part of a wide-complex tachycardia is visible.

Myocardial Infarction 52

Myocardial Infarction Tachycardia 52

All About Cardiovascular System and Disorders

FEBRUARY 6, 2024

ST Elevation Myocardial Infarction ECG

Myocardial Infarction 52

Myocardial Infarction Electrophysiology 52

The American Journal of Cardiology

MARCH 24, 2024

The Universal definition (UD) of Myocardial Infarction (MI) has been an important contribution to the literature and has, among other aims, helped exp…

Myocardial Infarction 40

Myocardial Infarction 40

JAMA Cardiology

MARCH 19, 2024

This Viewpoint discusses diagnosis of type 2 myocardial infarction.

Myocardial Infarction 63

Myocardial Infarction 63

HeartRhythm

APRIL 30, 2024

Sudden cardiac death (SCD) risk stratification is based on clinically recognized risk factors (RF), such as reduced left ventricular (LV) ejection fraction (EF), heart failure (HF), prior myocardial infarction (MI), and syncope. These RFs fail to capture the majority of SCDs.

Sudden Cardiac Death 40

Sudden Cardiac Death Myocardial Infarction Cardiomyopathy Heart Failure 40

Heart BMJ

MARCH 22, 2024

Objective To investigate the incidence and mortality risk associated with postdischarge major bleeding after coronary artery bypass grafting (CABG), and relate this to the incidence of, and mortality risk from, postdischarge myocardial infarction. Myocardial infarction was associated with higher mortality risk <30 days (aHR=20.0 (95%

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft Myocardial Infarction Hospital 40

Cardiovascular Diabetology

JANUARY 21, 2024

It is well-known that systemic inflammation plays a crucial role in the pathogenesis and prognosis of acute myocardial infarction (AMI). The systemic immune-inflammation index (SII, platelet × neutrophil/lymph.

Myocardial Infarction 72

Myocardial Infarction Diabetes Research 72

HeartRhythm

APRIL 30, 2024

We have shown that myocardial infarction (MI) leads to sympathetic hypo-innervation due to the presence of chondroitin sulfate proteoglycans in the infarct that prevent re-innervation.

Myocardial Infarction 40

Myocardial Infarction Arrhythmia 40

Heart BMJ

MARCH 12, 2024

Learning objectives To review the epidemiology, clinical presentation and diagnosis of mechanical complications of acute myocardial infarction including ventricular septal defect, free wall rupture and papillary muscle rupture. To discuss the existing data on outcomes of medical therapy, surgery and percutaneous intervention.

Myocardial Infarction 40

Myocardial Infarction VSD Outcomes 40

Frontiers in Cardiovascular Medicine

FEBRUARY 20, 2024

Chronic obstructive pulmonary disease (COPD), particularly following acute exacerbations (AE-COPD), significantly heightens the risks and mortality associated with acute myocardial infarction (AMI).

Myocardial Infarction 64

Myocardial Infarction Pulmonary Research 64

American College of Cardiology

JANUARY 23, 2024

Both the COMPLETE and PRAMI trial findings supported the benefits of complete revascularization over culprit-only percutaneous coronary intervention (PCI) in patients presenting with myocardial infarction (MI) and multivessel coronary artery disease.

Myocardial Infarction 69

Myocardial Infarction Coronary Artery Disease Article 69

HeartRhythm

APRIL 30, 2024

However, whether cardiac spinal afferent blockade can prevent or revert cardiac autonomic imbalance after chronic myocardial infarction (MI) and reduce occurrence of ventricular tachyarrhythmias (VT/VF) remains unknown. Cardiac spinal afferent signaling significantly contributes to sympathoexcitation and may reduce vagal tone.

Myocardial Infarction 40

Myocardial Infarction Arrhythmia 40

Frontiers in Cardiovascular Medicine

MARCH 19, 2024

Therefore, this paper proposes a novel cost-sensitive deep neural network (CSDNN)-based mortality prediction model for out-of-hospital acute myocardial infarction (AMI) patients with hypertension on imbalanced data. Methods The synopsis of our research is as follows.

Myocardial Infarction 64

Myocardial Infarction Hypertension Risk Factors Cardiovascular Disease 64

Frontiers in Cardiovascular Medicine

JANUARY 14, 2024

Background The objective of this study was to investigate the differences in presenting symptoms between patients with and without diabetes being diagnosed with an acute myocardial infarction (AMI). Methods A total of 5,900 patients with a first-time AMI were included into the analysis.

Myocardial Infarction 64

Myocardial Infarction Diabetes Chest Pain Risk Factors 64

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

Background Different ST-segment elevation myocardial infarction (STEMI) localizations go along with dissimilarities in the size of the affected myocardium, the causing coronary vessel occlusion, and the right ventricular participation. years, (standard deviation: 3.0).

Myocardial Infarction 59

Myocardial Infarction STEMI 59

Cardiovascular Diabetology

DECEMBER 11, 2023

Previous observational studies have documented an inverse association of birthweight with myocardial infarction (MI) but a positive association with atrial fibrillation (AF). However, the causality of these as.

Myocardial Infarction 59

Myocardial Infarction Atrial Fibrillation Document Research 59

HeartRhythm

APRIL 30, 2024

Myocardial infarction (MI) is a major risk factor for SCD associated with significant pro-arrhythmic structural and electrophysiological ventricular remodelling. Sudden cardiac death (SCD) is one of the most important causes of mortality in the world.

Myocardial Infarction 40

Myocardial Infarction Sudden Cardiac Death Electrophysiology Risk Factors 40

Journal of Cardiothoracic Surgery

MARCH 29, 2024

Accurately predicting post-discharge mortality risk in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI) remains a complex and critic.

Myocardial Infarction 52

Myocardial Infarction STEMI Research 52

HeartRhythm

APRIL 30, 2024

Morbidity and mortality rates after Myocardial Infarction (MI) remain high despite advancements in therapy. Post-MI cardiac remodeling leads to heart failure and electrical aberrancies which result in lethal arrhythmias and sudden cardiac death.

Myocardial Infarction 40

Myocardial Infarction Sudden Cardiac Death Heart Failure Arrhythmia 40

HeartRhythm

APRIL 30, 2024

Wide complex tachycardias (WCT) in patients after myocardial infarction (MI) are often VT. A correct diagnosis is vital.

Myocardial Infarction 40

Myocardial Infarction Tachycardia 40

The New England Journal of Medicine

NOVEMBER 10, 2023

In patients with myocardial infarction and anemia, a liberal transfusion strategy led to fewer deaths and heart attacks than a restricted transfusion strategy, but the difference was of borderline significance.

Myocardial Infarction 40

Myocardial Infarction Heart Attack Heart attacks 40

HCPLive

APRIL 12, 2024

Ankeet Bhatt, MD, MBA, discusses a NUDGE-FLU analysis from ACC.24 24 examining effect of the CV gain-framed nudge in patients with and without history of AMI.

Myocardial Infarction 119

Myocardial Infarction 119

Coronary Artery Disease Journal

OCTOBER 23, 2023

Background Acute myocardial infarction (AMI) is one of the most lethal complications of COVID-19 hospitalization. In this study, we looked for the occurrence of AMI and its effects on hospital outcomes among COVID-19 patients. Methods Data from the 2020 California State Inpatient Database was used retrospectively.

COVID-19 52

COVID-19 Myocardial Infarction Hospital ICU 52

Journal of the American Heart Association

FEBRUARY 13, 2024

BackgroundThe left ventricular remodeling (LVR) process has limited the effectiveness of therapies after myocardial infarction. ConclusionsAT1R‐AAs and ETAR‐AAs are associated with LVR in patients with ST‐segment–elevation myocardial infarction. Forty‐one (31%) patients experienced LVR.

Myocardial Infarction 45

Myocardial Infarction Heart Failure Risk Factors Hospital 45

Circulation: Cardiovascular Quality & Outcomes

JANUARY 19, 2024

Background:Type 2 myocardial infarction (T2MI) and type 1 myocardial infarction (T1MI) differ with respect to demographics, comorbidities, treatments, and clinical outcomes. This could facilitate more accurate longitudinal assessments of acute myocardial infarction quality and outcomes. T1MI and 53.5%

Myocardial Infarction 40

Myocardial Infarction COVID-19 Medicare Hospital 40

Nature Reviews - Cardiology

DECEMBER 4, 2023

Nature Reviews Cardiology, Published online: 05 December 2023; doi:10.1038/s41569-023-00974-z Author Correction: Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction

Myocardial Infarction 40

Myocardial Infarction 40

Frontiers in Cardiovascular Medicine

JANUARY 2, 2024

Background Despite the crucial role of Chest pain centers (CPCs) in acute myocardial infarction (AMI) management, China's mortality rate for ST-segment elevation myocardial infarction (STEMI) has remained stagnant.

Myocardial Infarction 59

Myocardial Infarction Chest Pain COVID-19 Catheterization Laboratory 59

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

Introduction Differences in pathophysiology, clinical presentation, and natural course of ST-elevation myocardial infarction in female patients due to either spontaneous dissection (SCAD-STEMI) or atherothrombotic occlusion (type 1 STEMI) have been discussed. vs. 1.8 ± 5.1%, p  = 0.002).

Myocardial Infarction 59

Myocardial Infarction SCAD STEMI Thrombolysis 59

Circulation: Cardiovascular Interventions

JANUARY 31, 2024

BACKGROUND:In patients with ST-segment–elevation myocardial infarction complicated by cardiogenic shock, primary percutaneous coronary intervention (pPCI) is the preferred revascularization option. Circulation: Cardiovascular Interventions, Ahead of Print. pharmacoinvasive and 46.2% pharmacoinvasive and 46.2% 1.09];P=0.08).CONCLUSIONS:In

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Cardiac Arrest Cardiovascular Interventions 40

Frontiers in Cardiovascular Medicine

JANUARY 3, 2024

Background Microcirculatory dysfunction is an independent risk factor for a poor prognosis after percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI). Cardiac function was measured by echocardiography during hospitalization and follow-up.

Myocardial Infarction 59

Myocardial Infarction Cardiac Function Outcomes Thrombolysis 59

All About Cardiovascular System and Disorders

FEBRUARY 27, 2024

Higher risk of myocardial infarction, heart failure and atrial fibrillation was noted in spinal cord injury survivors compared to controls. Increased Risk of Myocardial Infarction, Heart Failure, and Atrial Fibrillation After Spinal Cord Injury. Survivors with severe disability had the highest risk. Am J Phys Med Rehabil.

Myocardial Infarction 40

Myocardial Infarction Atrial Fibrillation Heart Failure Blood Pressure 40